Tilfrinib (compound 4f) is a potent and selective Brk/PTK6 inhibitor with an IC 50 value of 3.15 nM for Brk . Tilfrinib shows good anti-proliferative activity and has potential of anti-tumour.
Products | Products > Disease Areas > Cancer | Products > Signaling Pathways > Protein Tyrosine Kinase/RTK | Products > Research Areas > Cancer | Products > Research Areas > Cancer > Cancer Targeted Therapy | Products > Signaling Pathways > BRK
Please leave a message for us or use the following ways to contact us, we will reply to you as soon as possible, and provide you with the most sincere service, thank you.